Status:
COMPLETED
Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis
Lead Sponsor:
NeoStrata Company, Inc.
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a 12 week bilateral study, consisting of 6 weeks of treatment and 6 weeks of follow-up. The purpose of the study is to compare the safety and effectiveness of combining and then following a hi...
Detailed Description
Superpotent topical corticosteroids such as clobetasol propionate are highly effective in treating plaque psoriasis but are not indicated for long term use due to their side effects. Therefore, steroi...
Eligibility Criteria
Inclusion
- 18 years of age or older
- able to provide written informed consent
- able to attend study visits, apply medications, and follow instructions
- moderate to severe localized plaque psoriasis lesions (\<10% BSA on each side of the body)
Exclusion
- other current treatments for psoriasis
- hypersensitivity to steroids, liquor carbonis detergens, alcohol, fragrance
- pregnant or nursing
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00769184
Start Date
October 1 2008
End Date
April 1 2009
Last Update
August 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Windsor Dermatology
East Windsor, New Jersey, United States, 08520